News
Merck launches $895M Kansas factory expansion amid push to increase domestic production
Merck is expanding domestic manufacturing with a $895 million investment in its Kansas factory, one of several major projects in the company's strategy to increase U.S. production in the coming years as President Donald Trump’s tariffs rattle the industry.
Merck CEO Robert Davis spoke about the new state-of-the-art biologics center slated to be based in Wilmington, Delaware that ...
U.S. drugmaker Merck said on Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it ...
Gov. Laura Kelly and Merck Animal Health — a veterinary medicine company — announced an $895 million expansion project at the ...
Merck is particularly exposed to the tariff threat, as much of its production of Keytruda takes place at facilities in ...
Merck announced on Tuesday that it is investing $1 billion in a new Delaware plant to expand domestic production as it ...
Here’s what to know. In February, Merck officials presented to Delaware’s Council of Development Finance to make their ...
It will build a Wilmington, Delaware facility dedicated to making its cancer drug, Keytruda, for U.S. patients.
The S&P 500, the Dow Jones, and the NASDAQ all moved between 0.8% and 1% lower by mid-afternoon. Palantir (PLTR) stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback